Delivery Order SPE2DP20D0002-SPE2DP24F3170
Award Date 3/13/24
Potential Completion Date 3/26/24
Potential Value $159K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. This delivery order is not set aside and is part of a larger $5.7 million indefinite-delivery contract (IDC) that establishes Teva as the national prime vendor to supply Levalbuterol HCL solution to the Department of Defense (DOD), Department of...
- The federal contract award, with ID SPE2DP20D0002|SPE2DP24F6264, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $476,414.19, is for the delivery of Adenovirus Type 4 vaccine, a critical product supporting military immunization programs. This is a delivery order contract with a firm-fixed price pricing type, and the ultimate completion date is July 30,...
- This federal contract award, identified as SPE2DP20D0002|SPE2DP24F6271, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, a critical product supporting military immunization programs. This is a Firm Fixed Price Delivery Order contract, with a period of performance through July 30, 2024. The contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The $271,494.00 order has a completion date of November 17, 2020. Teva has received numerous delivery orders from DLA to supply adenovirus vaccine to support military immunization programs. The company also holds active indefinite delivery/indefinite quantity (IDIQ)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This order has a completion date of January 30, 2024 and is not a set-aside contract. Teva Pharmaceuticals USA, Inc. provides critical pharmaceutical products to federal agencies like the Department of Veterans Affairs (VA), Department of Defense (DOD),...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 firm fixed-price delivery order is for the supply of Adenovirus Type 4 vaccines, supporting military immunization programs. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global Teva Pharmaceutical Industries Ltd. and has numerous prime contract awards with federal agencies, including...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract has a firm-fixed price of $317,609.46 and a completion date of July 30, 2024. Teva Pharmaceuticals USA, Inc. is a significant supplier of critical pharmaceutical products to various U.S. federal government agencies, including the Department of Veterans...
- This is a $476,414.19 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of Adenovirus Type 4 vaccine, a critical product for military immunization programs. The $158,804.73 firm-fixed-price contract has a period of performance through March 26, 2024. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts and delivery orders from...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies,...